Breast implants are medical devices that are used to augment breast size or to reconstruct the breast following mastectomy or to correct a congenital abnormality. Breast implants consist of a silicone outer shell and a filler (most commonly silicone gel..
The FDA has identified a possible association between breast implants and the development of anaplastic large cell lymphoma (ALCL), a rare type of non-Hodgkin?s lymphoma. ALCL is not cancer of the breast tissue. The FDA believes that women with breast...
Two lots recalled. Contamination thought to be the result of a chemical preservative applied to wood used in the construction of pallets on which materials are transported and stored.
This product was NOT distributed in the U.S. The product was only distributed in France on October 5, 2010.
To discuss Industry?s proposals for the next reauthorization, as well as present data on workload issues and discuss additional FDA proposals.
Failure may result in vessel wall injury, increased procedure time and/or emergency surgery to remove the partially deployed stent.
Results of a randomized, double-blind, placebo-controlled clinical trial of 700 smokers reviewed.
Draft Guidance for Industry and FDA Staff - Establishing the Performance Characteristics of In Vitro Diagnostic Devices for the Detection of methicillin-resistant Staphylococc...June 15, 2011 6:30 am | by U.S. Food & Drug Administration | News | Comments
FDA is issuing this draft guidance to provide industry and agency staff with recommendations for studies to establish the analytical and clinical performance of in vitro diagnostic devices (IVDs) intended for the detection of methicillin-resistant...
Boston Scientific iCross and Atlantis SR Pro 2 Coronary Imaging Catheters: Recall â€“ Catheter Tip Can Break Inside of the PatientJune 14, 2011 10:30 am | by U.S. Food & Drug Administration | News | Comments
Risk of embolization causing tissue and blood vessel injury, heart attack or other serious events.
Consequences may include the inability to decrease already-present ischemia, thrombus formation, organ injury or other serious events.
Terumo Coronary Ostia Cannula 10, 12, 14 Fr: Recall â€“ Fragments of Adhesive and Plastic in the Cannula Tip May EmbolizeJune 14, 2011 9:30 am | by U.S. Food & Drug Administration | News | Comments
Risk of arterial injury, hemorrhaging, or other serious events.
Reason for Recall: Foreign fragments of adhesive and plastic in the cannula tip may embolize causing arterial injury, hemorrhaging or other serious events requiring unplanned surgery.
Reason for Recall: A defective fan in the power supply may cause overheating and shut down the device without visible or audible alarms. Consequences of unanticipated interruption of therapy may include the inability to decrease already-present ischemia..
This website has been translated to Spanish from English, and is updated often. It is possible that some links will connect you to content only available in English or some of the words on the page will appear in English until translation has been completed (usually within 24 hours). We appre
Oridion Medical and Philips Healthcare Microstream CO2 Filterline (FilterLine H Set Infant/Neonate, VitaLine H Set Infant/Neonate: Recall - Plastic Strands on the Adapter May ...June 7, 2011 6:30 am | by U.S. Food & Drug Administration | News | Comments
Inhalation of the plastic strands may cause respiratory compromise, which could result in serious illness or death.
Class I Medical Device Recall: Oridion Medical and Philips Healthcare Microstream CO2 Filterline (FilterLine H Set Infant/Neonate, VitaLine H Set Infant/Neonate)June 6, 2011 12:30 pm | by U.S. Food & Drug Administration | News | Comments
Reason for Recall: Fine plastic strands on the inner surface of the infant/neonatal airway adapter may become dislodged and inhaled by the patient. Inhalation of the plastic strands on the defective devices may cause respiratory compromise, which could...
These are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for April 2011.
Aidapak Services Repackaged Pharmaceuticals: Recall - Potential Cross Contamination with Beta Lactam ProductsJune 3, 2011 10:30 am | by U.S. Food & Drug Administration | News | Comments
Potential for serious anaphylactic reaction in patients with known hypersensitivity to beta-lactam or penicillin products.
Labeling, Approval Order, and Summary of Safety and Effectiveness for XIENCE nano? Everolimus Eluting Coronary Stent System (P070015S054).
Thermography is not a replacement for screening mammography and should not be used by itself to diagnose breast cancer.
FDA Safety Communication: Breast Cancer Screening - Thermography is Not an Alternative to MammographyJune 2, 2011 12:30 pm | by U.S. Food & Drug Administration | News | Comments
The FDA is issuing this communication to alert the public, including women and health care providers, that thermography is not a replacement for screening mammography and should not be used by itself to diagnose breast cancer. The FDA is not aware of any
Letter To Foreign and Domestic Medical Device and Component Establishments That May Be Affected by the March 2011 Japan Earthquake and TsunamiJune 1, 2011 12:30 pm | by U.S. Food & Drug Administration | News | Comments
Japan is a critical participant in the global medical device market. As you know, on March 11, 2011, a massive earthquake and tsunami occurred near the northeastern coast of Japan, followed by various aftershocks, causing extensive damage to this region..
FDA regulates and reviews drugs of abuse tests before they can be sold to consumers or healthcare professional in the United States. In its review, the FDA evaluates the design and performance of tests and sample collection systems to help ensure that...
CDRH is seeking a contractor to study rapid molecular diagnostic methods for detecting influenza, as it considers using them as faster and more accurate reference methods for premarket evaluation of influenza diagnostics.
An industry group is advising the FDA to not regulate certain mobile health (mHealth) products, which can include medical smart phone applications, because their “social benefit” outweighs their inherent low risk.